Report Detail

Request for Sample of this report

Pharma & Healthcare Global Cabazitaxel Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2791077
    • |
  • 31 July, 2019
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

Scope of the Report:
Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In the future, we predict that there will be more and more cabazitaxel suppliers as soon as Sanofi’s Cabazitaxel patent expired. By 2024, global production will be 1427.4 Kg.
Currently, there are four major cabazitaxel API suppliers globally, including Sanofi, Tapi Teva, Fuan Pharmaceutical Group and Fujian Yewpark Biological etc. Sanofi is the global leader in this industry. According to our research, Sanofi had provided 845.8 Kg cabazitaxel API in 2017, which account for 95.32% of global market.
The worldwide market for Cabazitaxel is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 230 million US$ in 2024, from 170 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Cabazitaxel in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Type I
Type II

Market Segment by Applications, can be divided into
Age Below 65
Age Above 65

There are 15 Chapters to deeply display the global Cabazitaxel market.
Chapter 1, to describe Cabazitaxel Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cabazitaxel, with sales, revenue, and price of Cabazitaxel, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cabazitaxel, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Cabazitaxel market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Cabazitaxel sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Cabazitaxel Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Type I
      • 1.2.2 Type II
    • 1.3 Market Analysis by Applications
      • 1.3.1 Age Below 65
      • 1.3.2 Age Above 65
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Nigeria Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Sanofi
      • 2.1.1 Business Overview
      • 2.1.2 Cabazitaxel Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Sanofi Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Tapi Teva
      • 2.2.1 Business Overview
      • 2.2.2 Cabazitaxel Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Tapi Teva Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Fuan Pharmaceutical Group
      • 2.3.1 Business Overview
      • 2.3.2 Cabazitaxel Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Fuan Pharmaceutical Group Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Fujian Yewpark Biological
      • 2.4.1 Business Overview
      • 2.4.2 Cabazitaxel Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Fujian Yewpark Biological Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Cabazitaxel Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Cabazitaxel Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Cabazitaxel Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Cabazitaxel Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Cabazitaxel Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Cabazitaxel Market Analysis by Regions

    • 4.1 Global Cabazitaxel Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Cabazitaxel Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Cabazitaxel Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Cabazitaxel Sales and Growth Rate (2014-2019)
    • 4.3 Europe Cabazitaxel Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Cabazitaxel Sales and Growth Rate (2014-2019)
    • 4.5 South America Cabazitaxel Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Cabazitaxel Sales and Growth Rate (2014-2019)

    5 North America Cabazitaxel by Countries

    • 5.1 North America Cabazitaxel Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Cabazitaxel Sales and Market Share by Countries (2014-2019)
      • 5.1.2 North America Cabazitaxel Revenue and Market Share by Countries (2014-2019)
    • 5.2 United States Cabazitaxel Sales and Growth Rate (2014-2019)
    • 5.3 Canada Cabazitaxel Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Cabazitaxel Sales and Growth Rate (2014-2019)

    6 Europe Cabazitaxel by Countries

    • 6.1 Europe Cabazitaxel Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Cabazitaxel Sales and Market Share by Countries (2014-2019)
      • 6.1.2 Europe Cabazitaxel Revenue and Market Share by Countries (2014-2019)
    • 6.2 Germany Cabazitaxel Sales and Growth Rate (2014-2019)
    • 6.3 UK Cabazitaxel Sales and Growth Rate (2014-2019)
    • 6.4 France Cabazitaxel Sales and Growth Rate (2014-2019)
    • 6.5 Russia Cabazitaxel Sales and Growth Rate (2014-2019)
    • 6.6 Italy Cabazitaxel Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Cabazitaxel by Countries

    • 7.1 Asia-Pacific Cabazitaxel Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Cabazitaxel Sales and Market Share by Countries (2014-2019)
      • 7.1.2 Asia-Pacific Cabazitaxel Revenue and Market Share by Countries (2014-2019)
    • 7.2 China Cabazitaxel Sales and Growth Rate (2014-2019)
    • 7.3 Japan Cabazitaxel Sales and Growth Rate (2014-2019)
    • 7.4 Korea Cabazitaxel Sales and Growth Rate (2014-2019)
    • 7.5 India Cabazitaxel Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Cabazitaxel Sales and Growth Rate (2014-2019)

    8 South America Cabazitaxel by Countries

    • 8.1 South America Cabazitaxel Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Cabazitaxel Sales and Market Share by Countries (2014-2019)
      • 8.1.2 South America Cabazitaxel Revenue and Market Share by Countries (2014-2019)
    • 8.2 Brazil Cabazitaxel Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Cabazitaxel Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Cabazitaxel Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Cabazitaxel by Countries

    • 9.1 Middle East and Africa Cabazitaxel Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Cabazitaxel Sales and Market Share by Countries (2014-2019)
      • 9.1.2 Middle East and Africa Cabazitaxel Revenue and Market Share by Countries (2014-2019)
    • 9.2 Saudi Arabia Cabazitaxel Sales and Growth Rate (2014-2019)
    • 9.3 UAE Cabazitaxel Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Cabazitaxel Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Cabazitaxel Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Cabazitaxel Sales and Growth Rate (2014-2019)

    10 Global Cabazitaxel Market Segment by Type

    • 10.1 Global Cabazitaxel Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Cabazitaxel Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Cabazitaxel Revenue and Market Share by Type (2014-2019)
    • 10.2 Type I Sales Growth and Price
      • 10.2.1 Global Type I Sales Growth (2014-2019)
      • 10.2.2 Global Type I Price (2014-2019)
    • 10.3 Type II Sales Growth and Price
      • 10.3.1 Global Type II Sales Growth (2014-2019)
      • 10.3.2 Global Type II Price (2014-2019)

    11 Global Cabazitaxel Market Segment by Application

    • 11.1 Global Cabazitaxel Sales Market Share by Application (2014-2019)
    • 11.2 Age Below 65 Sales Growth (2014-2019)
    • 11.3 Age Above 65 Sales Growth (2014-2019)

    12 Cabazitaxel Market Forecast (2019-2024)

    • 12.1 Global Cabazitaxel Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Cabazitaxel Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Cabazitaxel Market Forecast (2019-2024)
      • 12.2.2 Europe Cabazitaxel Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Cabazitaxel Market Forecast (2019-2024)
      • 12.2.4 South America Cabazitaxel Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Cabazitaxel Market Forecast (2019-2024)
    • 12.3 Cabazitaxel Market Forecast by Type (2019-2024)
      • 12.3.1 Global Cabazitaxel Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Cabazitaxel Market Share Forecast by Type (2019-2024)
    • 12.4 Cabazitaxel Market Forecast by Application (2019-2024)
      • 12.4.1 Global Cabazitaxel Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Cabazitaxel Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Cabazitaxel . Industry analysis & Market Report on Cabazitaxel is a syndicated market report, published as Global Cabazitaxel Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Cabazitaxel market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,236.40
      		4,854.60
      		6,472.80
      		532,022.40
      		798,033.60
      		1,064,044.80
      		290,336.40
      		435,504.60
      		580,672.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo